RedHill Biopharma Announces Up To $19.4 Million Private Placement
RedHill Biopharma, a partner of Cumberland Pharmaceuticals, announced a private placement to raise up to $19.4 million, consisting of $6 million in upfront gross proceeds and potential warrant proceeds. The offering involves the sale of 8,571,429 ADSs at $0.70 per share, accompanied by Series A-1 and A-2 warrants exercisable immediately.
Key figures
- Deal Value Usd
- 6000000
- Offering Price
- 0.7
- Shares Offered
- 8571429
- Series a1 warrant term
- 5 years
- Series a2 warrant term
- 18 months
- Potential warrant proceeds
- $13.4 million
- Series a1 warrant exercise price
- 0.86
- Series a2 warrant exercise price
- 0.7
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.